HomeInsightsMarket Capitalization

Market Capitalization of Emcure Pharmaceuticals Ltd

Market Capitalization of Emcure Pharmaceuticals Ltd

stocks purchased

₹ 1.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

8.9 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Market Cap

₹ 27386.16 crore

Last updated on: Dec 26, 2024

Key Highlights

  • The Market Cap of Emcure Pharmaceuticals Ltd is ₹ 27386 crore as of 26 Dec 24 .
  • The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 0 crore on March 2019 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1445 as of 26 Dec 15:30 .

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Emcure Pharmaceuticals Ltd

No data available

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Share Price

₹ 1445.7

20.80 (1.46%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241445.7
24 Dec 20241424.9
23 Dec 20241386
20 Dec 20241368.55
19 Dec 20241389.1
18 Dec 20241402.45
17 Dec 20241389.6
16 Dec 20241408.7
13 Dec 20241359.25
12 Dec 20241344.5

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Emcure Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Emcure Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals announces resignation of senior management personnel

Emcure Pharmaceuticals announced that Aravamuthan Balaji, President - IT & Digital and Sen...

Read more

29 Nov 2024 19:25

News

Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS

Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....

Read more

22 Nov 2024 17:56

News

Emcure Pharma Q2 PAT rises 38.2% YoY

In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...

Read more

08 Nov 2024 12:50

News

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

02 Nov 2024 13:58

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

31 Oct 2024 10:43

News

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

Read more

03 Oct 2024 10:15

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Emcure Pharmaceuticals Ltd Market Cap

What is the market cap of Emcure Pharmaceuticals Ltd?

As of December 26, 2024, Emcure Pharmaceuticals Ltd has a market capitalization of ₹27386.16, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Emcure Pharmaceuticals Ltd's market capitalization?

Emcure Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Emcure Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Emcure Pharmaceuticals Ltd's market capitalization change?

Emcure Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions